Byungyong Ahn

Prof. Byungyong Ahn

Department of Food Science and Nutrition, University of Ulsan, Ulsan 44610, Korea
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2013 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SCSehyun Chae
Sehyun Chae
BAByungyong Ahn
Byungyong Ahn
KBKyunghee Byun
Kyunghee Byun
YCYoung Min Cho
Young Min Cho
MYMyeong-Hee Yu
Myeong-Hee Yu
KPKyong Soo Park
Kyong Soo Park
Mitochondrial dysfunctions activate retrograde signaling from mitochondria to the nucleus. To identify transcription factors and their associated pathways that underlie mitochondrial retrograde signaling, we performed gene expression profiling of the cells engineered to have varying amounts of mitochondrial DNA with an A3243G mutation (mt3243) in the leucine transfer RNA (tRNALeu), which reduces the abundance of proteins involved in oxidative phosphorylation that are encoded by the mitochondrial genome. The cells with the mutation exhibited reduced mitochondrial function, including compromised oxidative phosphorylation, which would activate diverse mitochondrial retrograde signaling pathways. By analyzing the gene expression profiles in cells with the mutant tRNALeu and the transcription factors that recognize the differentially regulated genes, we identified 72 transcription factors that were potentially involved in mitochondrial retrograde signaling. We experimentally validated that the mt3243 mutation induced a retrograde signaling pathway involving RXRA (retinoid X receptor α), reactive oxygen species, kinase JNK (c-JUN N-terminal kinase), and transcriptional coactivator PGC1α (peroxisome proliferator–activated receptor γ, coactivator 1 α). This RXR pathway contributed to the decrease in mRNA abundances of oxidative phosphorylation enzymes encoded in the nuclear genome, thereby aggravating the dysfunction in oxidative phosphorylation caused by the reduced abundance of mitochondria-encoded enzymes of oxidative phosphorylation. Thus, matching transcription factors to differentially regulated gene expression profiles was an effective approach to understand mitochondrial retrograde signaling pathways and their roles in mitochondrial dysfunction.

5 February 2008 in Diabetologia
Verified
Journal Article
Closed access
PDF file
KPK. S. Park
K. S. Park
JCJuliana CN CN Chan
Juliana CN CN Chan
莊C莊立民 Lee-Ming Chuang
莊立民 Lee-Ming Chuang
SSS. Suzuki
S. Suzuki
EAE. Araki
E. Araki
FAfor The Study Group of Molecular Diabetology in Asia
for The Study Group of Molecular Diabetology in Asia

1 May 2010 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
SCSung Soo Chung
Sung Soo Chung
BAByungyong Ahn
Byungyong Ahn
MKMin Kim
Min Kim
HCHye Hun Choi
Hye Hun Choi
HPHo Seon Park
Ho Seon Park
KPKyong Soo Park
Kyong Soo Park
Here, we demonstrate that SENP2, a desumoylating enzyme, plays a critical role in the control of adipogenesis. SENP2 expression was markedly increased upon the induction of adipocyte differentiation, and this increase was dependent on protein kinase A activation. Remarkably, knockdown of SENP2 led to a dramatic attenuation of adipogenesis with a marked decrease in PPARγ and C/EBPα mRNA levels. Knockdown of SENP2 also caused a marked reduction in the level of C/EBPβ protein but not in that of C/EBPβ mRNA. Interestingly, sumoylation of C/EBPβ dramatically increased its ubiquitination and destabilization, and this increase could be reversed by SENP2. In addition, overexpression of C/EBPβ could overcome the inhibitory effect of SENP2 knockdown on adipogenesis. Furthermore, SENP2 was absolutely required for adipogenesis of preadipocytes implanted into mice. These results establish a critical role for SENP2 in the regulation of adipogenesis by desumoylation and stabilization of C/EBPβ and in turn by promoting the expression of its downstream effectors, such as PPARγ and C/EBPα.

1 July 2010 in Bone
Verified
Journal Article
Closed access
JAJee Hyun An
Jee Hyun An
JYJae-Yeon Yang
Jae-Yeon Yang
BAByungyong Ahn
Byungyong Ahn
SCSun Wook Cho
Sun Wook Cho
JJJu Yeon Jung
Ju Yeon Jung
CSChan Soo Shin
Chan Soo Shin

8 August 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
BAByungyong Ahn
Byungyong Ahn
MSMangala M. Soundarapandian
Mangala M. Soundarapandian
HSHampton Sessions
Hampton Sessions
SPSatyamaheshwar Peddibhotla
Satyamaheshwar Peddibhotla
GRGregory P. Roth
Gregory P. Roth
DKDaniel P. Kelly
Daniel P. Kelly
Intramuscular lipid accumulation is a common manifestation of chronic caloric excess and obesity that is strongly associated with insulin resistance. The mechanistic links between lipid accumulation in myocytes and insulin resistance are not completely understood. In this work, we used a high-throughput chemical biology screen to identify a small-molecule probe, SBI-477, that coordinately inhibited triacylglyceride (TAG) synthesis and enhanced basal glucose uptake in human skeletal myocytes. We then determined that SBI-477 stimulated insulin signaling by deactivating the transcription factor MondoA, leading to reduced expression of the insulin pathway suppressors thioredoxin-interacting protein (TXNIP) and arrestin domain–containing 4 (ARRDC4). Depleting MondoA in myocytes reproduced the effects of SBI-477 on glucose uptake and myocyte lipid accumulation. Furthermore, an analog of SBI-477 suppressed TXNIP expression, reduced muscle and liver TAG levels, enhanced insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. These results identify a key role for MondoA-directed programs in the coordinated control of myocyte lipid balance and insulin signaling and suggest that this pathway may have potential as a therapeutic target for insulin resistance and lipotoxicity.

17 March 2015 in Diabetes
Verified
Journal Article
Open access
PDF file
YKYoung Do Koo
Young Do Koo
JCJin Woo Choi
Jin Woo Choi
MKMyungjin Kim
Myungjin Kim
SCSehyun Chae
Sehyun Chae
BAByungyong Ahn
Byungyong Ahn
KPKyong Soo Park
Kyong Soo Park
Small ubiquitin-like modifier (SUMO)-specific proteases (SENPs) that reverse protein modification by SUMO are involved in the control of numerous cellular processes, including transcription, cell division, and cancer development. However, the physiological function of SENPs in energy metabolism remains unclear. Here, we investigated the role of SENP2 in fatty acid metabolism in C2C12 myotubes and in vivo. In C2C12 myotubes, treatment with saturated fatty acids, like palmitate, led to nuclear factor-κB–mediated increase in the expression of SENP2. This increase promoted the recruitment of peroxisome proliferator–activated receptor (PPAR)δ and PPARγ, through desumoylation of PPARs, to the promoters of the genes involved in fatty acid oxidation (FAO), such as carnitine-palmitoyl transferase-1 (CPT1b) and long-chain acyl-CoA synthetase 1 (ACSL1). In addition, SENP2 overexpression substantially increased FAO in C2C12 myotubes. Consistent with the cell culture system, muscle-specific SENP2 overexpression led to a marked increase in the mRNA levels of CPT1b and ACSL1 and thereby in FAO in the skeletal muscle, which ultimately alleviated high-fat diet–induced obesity and insulin resistance. Collectively, these data identify SENP2 as an important regulator of fatty acid metabolism in skeletal muscle and further implicate that muscle SENP2 could be a novel therapeutic target for the treatment of obesity-linked metabolic disorders.